Novel Treatment Combination Improves Progression-Free Survival in Metastatic, Estrogen-Receptor-Positive HER-2-Negative ...Dana-Farber Cancer Institute
Final analysis of Dana-Farber co-led phase 3 FLAURA2 study underscore benefits of adding chemotherapy to existing standa...Dana-Farber Cancer Institute
From left to right, Domènec Puig, Adnan Khalid and Hatem A. Rashwan, researchers of the study, leaded by Universitat Rov...Universitat Rovira i Virgili
